| scholarly article | Q13442814 |
| P50 | author | Carlos Vrins | Q84361553 |
| Albert K Groen | Q107788097 | ||
| P2093 | author name string | Folkert Kuipers | |
| Rick Havinga | |||
| Theo H van Dijk | |||
| Uwe J F Tietge | |||
| Jelske N van der Veen | |||
| Hester van Meer | |||
| Klaas Bijsterveld | |||
| P2860 | cites work | Accumulation of dietary cholesterol in sitosterolemia caused by mutations in adjacent ABC transporters | Q24290568 |
| Homozygous disruption of the murine mdr2 P-glycoprotein gene leads to a complete absence of phospholipid from bile and to liver disease | Q24322810 | ||
| A RAPID METHOD OF TOTAL LIPID EXTRACTION AND PURIFICATION | Q25939000 | ||
| An oxysterol signalling pathway mediated by the nuclear receptor LXR alpha | Q28294042 | ||
| Hepatobiliary cholesterol transport is not impaired in Abca1-null mice lacking HDL | Q28354252 | ||
| The diversity of Rab proteins in vesicle transport | Q29620216 | ||
| Initial hepatic removal of chylomicron remnants is unaffected but endocytosis is delayed in mice lacking the low density lipoprotein receptor | Q34350305 | ||
| Disruption of Abcg5 and Abcg8 in mice reveals their crucial role in biliary cholesterol secretion | Q34415865 | ||
| Mass isotopomer distribution analysis: a technique for measuring biosynthesis and turnover of polymers | Q35534139 | ||
| Mechanisms of disease: HDL metabolism as a target for novel therapies | Q36716433 | ||
| Targeted depletion of hepatic ACAT2-driven cholesterol esterification reveals a non-biliary route for fecal neutral sterol loss | Q39782322 | ||
| Inactivation of NPC1L1 causes multiple lipid transport defects and protects against diet-induced hypercholesterolemia. | Q40465662 | ||
| Molecular physiology of reverse cholesterol transport | Q40526401 | ||
| Stimulation of lipogenesis by pharmacological activation of the liver X receptor leads to production of large, triglyceride-rich very low density lipoprotein particles | Q40720835 | ||
| Role of liver in the maintenance of cholesterol and low density lipoprotein homeostasis in different animal species, including humans. | Q40782405 | ||
| Differentiation-dependent expression and localization of the class B type I scavenger receptor in intestine. | Q40803880 | ||
| Physical-chemical behavior of dietary and biliary lipids during intestinal digestion and absorption. 2. Phase analysis and aggregation states of luminal lipids during duodenal fat digestion in healthy adult human beings | Q41228115 | ||
| Contribution of newly synthesized cholesterol to rat plasma and bile determined by mass isotopomer distribution analysis: bile-salt flux promotes secretion of newly synthesized cholesterol into bile | Q42077204 | ||
| Validation of a dual-isotope plasma ratio method for measurement of cholesterol absorption in rats | Q43661928 | ||
| Increased hepatobiliary and fecal cholesterol excretion upon activation of the liver X receptor is independent of ABCA1. | Q44053787 | ||
| Stimulation of cholesterol excretion by the liver X receptor agonist requires ATP-binding cassette transporters G5 and G8. | Q44324697 | ||
| Sitosterolemia in ABC-transporter G5-deficient mice is aggravated on activation of the liver-X receptor. | Q44709473 | ||
| Increased fecal neutral sterol loss upon liver X receptor activation is independent of biliary sterol secretion in mice. | Q45212260 | ||
| Protein transduction of Rab9 in Niemann-Pick C cells reduces cholesterol storage. | Q46561954 | ||
| Regulation of direct transintestinal cholesterol excretion in mice | Q46568117 | ||
| Measurement of endogenous synthesis of plasma cholesterol in rats and humans using MIDA. | Q46713759 | ||
| The Rab8 GTPase regulates apical protein localization in intestinal cells | Q47068868 | ||
| Particle size determines the specificity of apolipoprotein E-containing triglyceride-rich emulsions for the LDL receptor versus hepatic remnant receptor in vivo | Q47307436 | ||
| Percent cholesterol absorption in normal women and men quantified with dual stable isotopic tracers and negative ion mass spectrometry. | Q50536911 | ||
| Enterohepatic circulation in the rat. | Q51831340 | ||
| Cholesterol is necessary for triacylglycerol-phospholipid emulsions to mimic the metabolism of lipoproteins | Q69201151 | ||
| Usefulness of gas chromatographic profiles of plasma total lipids in diagnosis of phytosterolemia | Q69643742 | ||
| Origins of neutral sterols in human feces studied by stable isotope labeling (D and 13C). Existence of an external secretion of cholesterol | Q70907278 | ||
| An improved gas-liquid chromatographic method for the determination of fecal neutral sterols | Q71710750 | ||
| Selective liver targeting of antivirals by recombinant chylomicrons--a new therapeutic approach to hepatitis B | Q71803044 | ||
| Quantitative aspects of the intestinal absorption and metabolism of cholesterol and beta-sitosterol in the rat | Q72229513 | ||
| Reevaluation and application of the dual-isotope plasma ratio method for the measurement of intestinal cholesterol absorption in the hamster | Q72389330 | ||
| Scavenger receptor BI promotes high density lipoprotein-mediated cellular cholesterol efflux | Q73596081 | ||
| Centripetal cholesterol flux to the liver is dictated by events in the peripheral organs and not by the plasma high density lipoprotein or apolipoprotein A-I concentration | Q77502910 | ||
| Direct intestinal cholesterol secretion contributes significantly to total fecal neutral sterol excretion in mice | Q81248705 | ||
| Metabolism of protein-free lipid emulsion models of chylomicrons in rats | Q93569163 | ||
| P433 | issue | 29 | |
| P407 | language of work or name | English | Q1860 |
| P1104 | number of pages | 9 | |
| P304 | page(s) | 19211-19219 | |
| P577 | publication date | 2009-05-05 | |
| P1433 | published in | Journal of Biological Chemistry | Q867727 |
| P1476 | title | Activation of the liver X receptor stimulates trans-intestinal excretion of plasma cholesterol | |
| P478 | volume | 284 |
| Q90043701 | A human-like bile acid pool induced by deletion of hepatic Cyp2c70 modulates effects of FXR activation in mice |
| Q27693251 | A new framework for reverse cholesterol transport: non-biliary contributions to reverse cholesterol transport. |
| Q26865600 | A new model of reverse cholesterol transport: enTICEing strategies to stimulate intestinal cholesterol excretion |
| Q28743016 | A reappraisal of the mechanism by which plant sterols promote neutral sterol loss in mice |
| Q57115936 | ABCG5 and ABCG8: more than a defense against xenosterols |
| Q35815267 | ABCG5/G8 deficiency in mice reduces dietary triacylglycerol and cholesterol transport into the lymph. |
| Q39020864 | Absence of intestinal microbiota increases ß-cyclodextrin stimulated reverse cholesterol transport |
| Q33894773 | Acceleration of biliary cholesterol secretion restores glycemic control and alleviates hypertriglyceridemia in obese db/db mice |
| Q33717139 | Acute sterol o-acyltransferase 2 (SOAT2) knockdown rapidly mobilizes hepatic cholesterol for fecal excretion |
| Q37013347 | Biliary and nonbiliary contributions to reverse cholesterol transport |
| Q34035681 | Biliary sterol secretion is not required for macrophage reverse cholesterol transport |
| Q48110789 | Blackcurrant anthocyanins stimulated cholesterol transport via post-transcriptional induction of LDL receptor in Caco-2 cells |
| Q34186425 | C57Bl/6 N mice on a western diet display reduced intestinal and hepatic cholesterol levels despite a plasma hypercholesterolemia |
| Q34258914 | Cell cholesterol homeostasis: Mediation by active cholesterol |
| Q90474062 | Chronic Activation of Liver X Receptor Sensitizes Mice to High Cholesterol Diet-Induced Gut Toxicity |
| Q35832477 | Combined effects of ezetimibe and phytosterols on cholesterol metabolism: a randomized, controlled feeding study in humans. |
| Q34049505 | Cooperative transcriptional activation of ATP-binding cassette sterol transporters ABCG5 and ABCG8 genes by nuclear receptors including Liver-X-Receptor |
| Q33608251 | Coordinated Actions of FXR and LXR in Metabolism: From Pathogenesis to Pharmacological Targets for Type 2 Diabetes |
| Q40252579 | Coordination of triacylglycerol and cholesterol homeostasis by DHR96 and the Drosophila LipA homolog magro |
| Q38874372 | Deficiency of the oxygen sensor prolyl hydroxylase 1 attenuates hypercholesterolaemia, atherosclerosis, and hyperglycaemia. |
| Q41090217 | Dietary oleic acid regulates hepatic lipogenesis through a liver X receptor-dependent signaling |
| Q37716347 | Differential impact of hepatic deficiency and total body inhibition of MTP on cholesterol metabolism and RCT in mice. |
| Q28073180 | Dynamics of hepatic and intestinal cholesterol and bile acid pathways: The impact of the animal model of estrogen deficiency and exercise training |
| Q84597568 | Effect of Huxin Formula on reverse cholesterol transport in ApoE-gene knockout mice |
| Q57109018 | Effect of the prebiotic fiber inulin on cholesterol metabolism in wildtype mice |
| Q57113067 | Effects of mulberry leaf on experimental hyperlipidemia rats induced by high-fat diet |
| Q37662885 | Ezetimibe inhibits hepatic Niemann-Pick C1-Like 1 to facilitate macrophage reverse cholesterol transport in mice |
| Q42957818 | Ezetimibe stimulates faecal neutral sterol excretion depending on abcg8 function in mice |
| Q37820951 | From blood to gut: direct secretion of cholesterol via transintestinal cholesterol efflux. |
| Q26997647 | From evolution to revolution: miRNAs as pharmacological targets for modulating cholesterol efflux and reverse cholesterol transport |
| Q35860010 | Future therapeutic directions in reverse cholesterol transport |
| Q27320737 | Hepatic farnesoid X-receptor isoforms α2 and α4 differentially modulate bile salt and lipoprotein metabolism in mice |
| Q40316798 | High-cholesterol diet does not alter gut microbiota composition in mice |
| Q45840153 | High-fat and fructose intake induces insulin resistance, dyslipidemia, and liver steatosis and alters in vivo macrophage-to-feces reverse cholesterol transport in hamsters |
| Q42398309 | Hypocholesterolaemic Activity of Lupin Peptides: Investigation on the Crosstalk between Human Enterocytes and Hepatocytes Using a Co-Culture System Including Caco-2 and HepG2 Cells |
| Q42150261 | In vivo tissue cholesterol efflux is reduced in carriers of a mutation in APOA1. |
| Q47791527 | Increased serum liver X receptor ligand oxysterols in patients with non-alcoholic fatty liver disease. |
| Q94480091 | Induction of fecal cholesterol excretion is not effective for the treatment of hyperbilirubinemia in Gunn rats |
| Q37511728 | Insig proteins mediate feedback inhibition of cholesterol synthesis in the intestine |
| Q37368738 | Intestinal CREBH overexpression prevents high-cholesterol diet-induced hypercholesterolemia by reducing Npc1l1 expression. |
| Q36822555 | Intestinal SR-BI does not impact cholesterol absorption or transintestinal cholesterol efflux in mice |
| Q38234847 | Intestinal nuclear receptors in HDL cholesterol metabolism |
| Q90636719 | Intestine-Specific Overexpression of LDLR Enhances Cholesterol Excretion and Induces Metabolic Changes in Male Mice |
| Q54324443 | LXRβ activation increases intestinal cholesterol absorption, leading to an atherogenic lipoprotein profile. |
| Q57113485 | Lack of Correlation of Plasma HDL With Fecal Cholesterol and Plasma Cholesterol Efflux Capacity Suggests Importance of HDL Functionality in Attenuation of Atherosclerosis |
| Q30426995 | Liver LXRα expression is crucial for whole body cholesterol homeostasis and reverse cholesterol transport in mice |
| Q39710752 | Liver X receptor activation promotes macrophage-to-feces reverse cholesterol transport in a dyslipidemic hamster model |
| Q36747243 | Liver X receptor agonist modulation of cholesterol efflux in mice with intestine-specific deletion of microsomal triglyceride transfer protein |
| Q38462005 | Liver X receptors as regulators of metabolism. |
| Q28082452 | Liver X receptors at the intersection of lipid metabolism and atherogenesis |
| Q38212170 | Liver X receptors in lipid metabolism: opportunities for drug discovery |
| Q57132485 | Measurement of Intestinal and Peripheral Cholesterol Fluxes by a Dual-Tracer Balance Method |
| Q37103346 | Novel role of a triglyceride-synthesizing enzyme: DGAT1 at the crossroad between triglyceride and cholesterol metabolism |
| Q57244090 | Overview of the Measurement of Lipids and Lipoproteins in Mice |
| Q34433146 | PCSK9 and LDLR degradation: regulatory mechanisms in circulation and in cells |
| Q38906357 | Phytosterol-mediated inhibition of intestinal cholesterol absorption in mice is independent of liver X receptor |
| Q39030661 | Pravastatin activates the expression of farnesoid X receptor and liver X receptor alpha in Hep3B cells |
| Q41849738 | Reduction of VLDL secretion decreases cholesterol excretion in niemann-pick C1-like 1 hepatic transgenic mice |
| Q89519102 | Regulation of intestinal lipid metabolism: current concepts and relevance to disease |
| Q36007212 | Regulation of reverse cholesterol transport - a comprehensive appraisal of available animal studies |
| Q35014254 | Relative roles of ABCG5/ABCG8 in liver and intestine |
| Q38735044 | Retrograde cholesterol transport in the human Caco-2/TC7 cell line: a model to study trans-intestinal cholesterol excretion in atherogenic and diabetic dyslipidemia |
| Q37820949 | Reverse cholesterol transport: from classical view to new insights. |
| Q28299162 | Role of the intestinal bile acid transporters in bile acid and drug disposition |
| Q48556275 | Roux-en-Y gastric bypass reduces plasma cholesterol in diet-induced obese mice by affecting trans-intestinal cholesterol excretion and intestinal cholesterol absorption. |
| Q34531158 | Statins increase hepatic cholesterol synthesis and stimulate fecal cholesterol elimination in mice |
| Q37573558 | Sterol O-Acyltransferase 2-Driven Cholesterol Esterification Opposes Liver X Receptor-Stimulated Fecal Neutral Sterol Loss |
| Q41833141 | Stimulation of murine biliary cholesterol secretion by thyroid hormone is dependent on a functional ABCG5/G8 complex. |
| Q91899830 | The Cholesterol-Lowering Effect of Oats and Oat Beta Glucan: Modes of Action and Potential Role of Bile Acids and the Microbiome |
| Q36610558 | The Impairment of Macrophage-to-Feces Reverse Cholesterol Transport during Inflammation Does Not Depend on Serum Amyloid A. |
| Q64237427 | The TICE Pathway: Mechanisms and Lipid-Lowering Therapies |
| Q35850568 | The TMAO-Generating Enzyme Flavin Monooxygenase 3 Is a Central Regulator of Cholesterol Balance |
| Q39442545 | The challenges and promise of targeting the Liver X Receptors for treatment of inflammatory disease. |
| Q35217035 | The combination of ezetimibe and ursodiol promotes fecal sterol excretion and reveals a G5G8-independent pathway for cholesterol elimination |
| Q43102238 | The effects of intrauterine malnutrition on maternal-fetal cholesterol transport and fetal lipid synthesis in mice |
| Q39746656 | Tissue-specific liver X receptor activation promotes macrophage reverse cholesterol transport in vivo |
| Q42129050 | Trans-intestinal cholesterol efflux is not mediated through high density lipoprotein. |
| Q36683297 | Transcriptional integration of metabolism by the nuclear sterol-activated receptors LXR and FXR. |
| Q37033119 | Transintestinal transport of the anti-inflammatory drug 4F and the modulation of transintestinal cholesterol efflux |
| Q57810328 | Trimethylamine -Oxide: A Link among Diet, Gut Microbiota, Gene Regulation of Liver and Intestine Cholesterol Homeostasis and HDL Function |
| Q36607669 | Trust your gut: galvanizing nutritional interest in intestinal cholesterol metabolism for protection against cardiovascular diseases |
| Q35747737 | Type I diabetes mellitus decreases in vivo macrophage-to-feces reverse cholesterol transport despite increased biliary sterol secretion in mice |
| Q93077801 | Vertical Sleeve Gastrectomy Attenuates the Progression of Non-Alcoholic Steatohepatitis in Mice on a High-Fat High-Cholesterol Diet |
Search more.